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Introduction
Critical-sized bone defect does not heal spontaneously and will be occupied by connective tissue. Therefore, treatment of such defects remains a great challenge to clinicians [1] . Autologous bone grafting is a well-established clinical procedure and is considered gold standard for bone defect repair. However, autografting is limited by bone availability, donor site morbidity and postoperative complications [2] . In recent years, bone tissue engineering has attracted more attention as a promising treatment for bone defect. Successful tissue engineering contains three factors: seed cells, biomaterials and bioactive molecules. Mesenchymal stem cells (MSCs) are an attractive cell type for tissue engineering due to their multi-lineage differentiation capabilities including osteoblast, adipocytes and chondrocytes [3, 4] . Human dental pulp-derived mesenchymal stem cells (hDPSCs) are easily accessible from the permanent human dental pulp through a slightly uncomfortable procedure [5, 6] . hDPSCs are derived from mesenchyme and neural crest, and thus possess several properties of MSCs [5, 7, 8] . In addition, these cells exhibit higher proliferative, mineralization, and immunoregulatory capacities compared with bone marrow-derived MSCs and maintain multi-lineage differentiation potentials even after long-term cryopreservation [9, 10] . These characteristics render hDPSCs as suitable seed cells for cell-based therapeutics and tissue engineering [11, 12] . Especially, hDPSCs have been demonstrated to be successfully employed as a promising therapeutic tool for bone defects repair [11, 13, 14] .
The pannexin (Panx) family consists of three glycoproteins (Panx1, Panx2, and Panx3), which form hemichannels and facilitate the passage of ions and small molecules (such as calcium and ATP) from the intercellular space to the extracellular microenvironment [15] . Panx3 has been reported to promote osteogenic and chondrogenic differentiation in mice progenitor cells [15, 16] . However, the expression tendency and role of Panx3 in primary hDPSCs during osteogenic differentiation is still unclear, and the expression pattern and mediatory effects of Panx3 might differ across various cells and species. For example, the expression profile and role of other factors such as miR-34a varies during osteogenic differentiation among different cells [17, 18] . Clarifying the role and molecular mechanisms by which Panx3 controls osteogenic differentiation of hDPSCs and elucidating the boneforming ability of Panx3-modified hDPSCs in vivo will provide a more complete understanding of osteogenesis of hDPSCs and drive the application of gene therapy for bone repair through regulation of key factors.
In this study, we systematically investigated the effect of Panx3 on osteogenic differentiation of hDPSCs and the underlying mechanism by employing Panx3 loss-and gain-of function approaches. Furthermore, we explored the bone-forming ability of Panx3-modified hDPSCs using a rat cranial critical-sized bone defect model. We anticipated that this model could be a meaningful paradigm for cell-based therapy of Panx3-modified hDPSCs.
Materials and Methods:

Plasmid construction
The plasmid constructs Wnt3a-pUSEamp, pUSEamp, TOPflash, FOPflash and pGL3-Basic were purchased from Millipore (Billerica, MA, USA). pGL3-Basic and pRL-TK were purchased from promega (Madison, WI, USA). shRNA targeting the human Panx3 gene named lenti-shRNA-Panx3 and human β-catenin were purchased from Genechem (Shanghai, China).
Putative Panx3 promoter fragment were cloned using genomic DNA as template according to the manufacture's instruction of Prime STAR Max DNA (Takara Bio Inc, Shiga, Japan). The primers were listed in Table1. The product was directionally cloned into Kpnl and Xhol restriction sites of pGL3-Basic, named Panx3-promoter (Fig. 4F) .
The Panx3 overexpression plasmid was constructed according to previous study [19] . Briefly, the fulllength of Panx3 CDS was directionally cloned and inserted into pLVX-IRES-ZsGreen1, named lenti-Panx3.
pLVX-IRES-ZsGreen1 (lenti-Plvx) and a nonsense shRNA sequence exhibiting no homology to the Panx3 (lenti-shRNA-Ctrl) were employed as negative controls.
Generation of Wnt3a-conditioned medium HEK293E were transfected using Lipofectamine 2000 (invitrogen, CA, USA) with the Wnt3a-pUSEamp to generate Wnt3a-conditioned medium. The pUSEamp was used as control. After transfection for 6 h, the medium was discarded and replaced with fresh medium. After incubation for 48 h, the culture supernatants were harvested, filtered using a 0.22 μm filter, and designated as Wnt3a-conditioned medium and control.
Cell culture and treatment of hDPSCs
Healthy third molars and premolars were collected from 15-25-year-old patients with informed consents undergoing extraction at the School and Hospital of Stomatology, Wuhan University, which was approved by the Institutional Ethical Board of Wuhan University. The pulp tissues were immediately extracted, minced into pieces and digested with the mixture of 3 mg/mL collagenase I (Life Technologies Europe B.V., Zug ZG, Switzerland) and 4mg/ml dispase (Roche Applied Science, Mannheim, Germany) for 1 h at 37°C on shaker to obtain single-cell suspensions [20] . Primary cells were cultured in α-MEM (minimal essential medium, α modification) (Hyclone, Logan, UT, USA) containing 10% fetal bovine serum (FBS) (Hyclone) and 1% penicillin/streptomycin (P/S, Jinuo, Hangzhou, China) at 37°C in humidified atmosphere of 5% CO 2, and the medium was refreshed every 3 days. hDPSCs were passaged upon reaching 70-80% confluence, and the cells at passage 3-5 were used for following studies. To induce osteogenic differentiation, the hDPSCs were induced using osteogenic induction medium (OM) (complete medium supplemented with 50 ug/mL l-ascorbic acid (Sigma-Aldrich), 10 mM β-glycerophosphate (Sigma-Aldrich), and 10 nM dexamethasone (Sigma-Aldrich)). In particular experiments, hDPSCs were grown in the presence of indicated concentration of Wnt3a-conditioned medium (0, 10%, 20%, 40% and 80%) and LiCl (0mM, 5mM, 10mM and 20mM) for 24 h.
Lentivirus production and transduction
Lentiviruses were produced through transfecting HEK293E with a three-plasmid system, including lentiviral vector, psPAX2, and pMD2.G, using Turbofect (Thermo, MA, USA) according to previous study [19] . hDPSCs were infected with lentivirus in the presence of polybrene (6 μg/mL; Sigma-Aldrich, St. Louis, MO, USA) for 12-24h. The infection efficiency was evaluated by fluorescent microscope, qRT-PCR and Western blot.
CCK-8 cell proliferation assay
To assess the effect of Panx3 on the proliferation of hDPSCs, CCK-8 (Dojindo Molecular Technology, Kumamoto, Japan) assay was performed. 10μl CCK-8 mixed with 90μl complete medium was added to each well for incubation 2 hr. The absorbance of the supernatant was read at 450nm using a microplate reader (PowerWave XS2, BioTek, USA).
ALP staining and Alizarin red staining
Transduced hDPSCs were cultured in OM for indicated period prior to the following procedures. Cells were fixed in 4% paraformaldehyde for 15 min and washed twice with PBS. ALP staining solution containing naphthol AS-MX phosphate (Sigma-Aldrich) and fast red violet LB salt (Sigma-Aldrich) was freshly prepared and added into the wells, and then incubated at 37°C for 30-60 min. The wells were photographed and the percentages of ALP-positive cells in each group were calculated.
After culture in OM for 14 d, the mineralized nodule formation was assessed by staining with 2% alizarin red solution (pH=4.2). After incubation for 30 min at 37°C, the non-specific staining was washed with distilled water twice. Then the plates were photographed. For quantitative analysis, the mineralized nodule was desorbed with 10% (w/v) cetylpyridinium chloride (Sigma-Aldrich) for 30 min. The OD values of the supernatants were measured at 570 nm on an absorbance microplate reader and normalized to total protein concentration.
ALP activity
At the designated time point, ALP activity was processed. The cells were lysed by 1% triton for 30 min, and then fresh p-nitrophenyl phosphate (p-NPP) (Sigma-Aldrich) as substrate was incubated at 37°C for 15min. The OD values were read spectrophotometrically at 405 nm. The p-Nitrophenol (Sigma-Aldrich) was used for fabrication of the standard curve. Relative ALP activity was normalized by the total protein concentration. qRT-PCR Total RNA was collected from cultured cells using TRIzol (Invitrogen, MA, USA). 1ug RNA was used to transcribe by using PrimeScript™ RT Reagent Kit with gDNA Eraser (Takara Bio Inc). Then, qRT-PCR was run on the ABI-7500 Real-Time PCR System (Applied Biosystems, CA, USA) with the SYBR Green I dye (Takara) in triplicates. The glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as an internal control. The sequences of primers were listed in Table 1 . 2^-∆∆Ct was used to calculate the relative fold change of gene expression.
Western blot analysis
Total protein was collected from hDPSCs using RIPA lysis buffer supplemented with PMSF (Roche Applied Science, Mannheim, Germany) and phosphatase inhibitors (Roche Applied Science), and then protein concentration was determined using a BCA assay kit. Next, equal amounts of proteins were loaded on SDS-PAGE gel and transferred to methanol treated PVDF membrane. After blocking with 5% non-fat milk, the membranes were incubated with anti-Panx3 (Invitrogen), anti-Dentin sialoprotein (DSP) (Santa Cruz, CA, USA), anti-phospho-β-catenin (Cell Signaling Technology, Danvers, MA, USA), anti-β-catenin (Abcam, Cambridge, MA, USA), anti-ERK1/2 (Cell Signaling Technology), anti-phospho-ERK1/2 (Cell Signaling Technology) antibodies at 4˚C with constant rocking and then incubated with horseradish peroxidase (HRP)-labeled secondary antibody (Biosharp, Hefei, China) for 1hr at room temperature. The HRP Conjugated Anti-GAPDH (1:10, 000, mouse monoclonal) antibody was used as an internal control. The immunoblots were detected using an ECL kit, and visualized using X-ray film. The relative density was calculated by image J (National Institutes of Health).
Dual luciferase reporter assay hDPSCs were transducted with 0.5μg Panx3-promoter or 0.5 μg empty pGL3-Basic vectors and 0.05μg pRL-TK plasmid by using Lipofectamine 2000 following the manufacturer's instructions. After transfection for 6 hr, the supernatants were discarded and replaced with fresh medium supplemented with LiCl (20 mM) or vehicle for another 24hr. Firefly and Renilla luciferase activities were measured using the Dual Glo luciferase assay system (Promega) according to the manufacturer's instructions (Promega). The ratio of Panx3-promoter/ pGL3-Basic was then analyzed.
Transfected hDPSCs were co-transfected with the reporter plasmid TOPflash or FOPflash and the internal control plasmid pRL-TK at a ratio of 10:1. The ratio of TOPflash/FOPflash was analyzed.
Animal experiments
The bone-forming ability of transfected cells in scaffolds was assessed in a calvarial critical-sized defect model of SD rats. All the animal procedures were approved by the Institutional Ethical Board of Wuhan University and conducted in accordance with the NIH guidelines. For cell seeding, the genetically modified hDPSCs were concentrated to 1 × 10 6 cells per 50 μl of the medium and then dropped on 30 mg of wet β-TCP particles (diameter < 1 mm, pore size ≈ 500 μm, porosity ≈ 75%; Shanghai Bio-lu Biomaterials Co., Ltd, China). Twelve 8-week-old male SD rats were purchased from the Hubei Research Center of Laboratory Animals and housed under specific pathogen free-condition in the laboratory. A 5-mm-diameter defect was drilled on both sides of rat calvarial bones. All of the 24 critical-sized defects were divided into four groups: blank group (n=6), β-TCP group (n=6), hDPSCs/Plvx-β-TCP group (n=6), and hDPSCs/Panx3-β-TCP group (n=6).
Micro-CT
All rats were sacrificed 8 weeks postoperation, the calvarial bones were harvested and fixed in 4% paraformaldehyde. All samples were scanned using μCT50 imaging system (Scanco Medical, Switzerland) with the same parameters used previously [21] . Bone formation volume was calculated for bone regeneration.
Histological evaluation
All samples were decalcified using 10% EDTA until could be penetrated by needle without resistance before embedding in paraffin. HE, Masson and TRAP staining were conducted separately on serial sections. Masson staining was conducted according to the manufacturer's instructions (Maixin Biotech, Fuzhou, China). A leukocyte-specific acid phosphatase kit (Sigma-Aldrich) was used to detect Tartrate-resistant acid phosphatase (TRAP) activity. For morphometric analysis, newly formed bone area fold changes in Massonstained sections were quantified in 5 sections of at least 5 different defects for each group.
Double immunofluorescence staining for OCN and GFP
Sections were incubated with the mixture of rabbit anti-Osteocalcin (OCN) (Santa Cruz) and mouse anti-GFP (Santa Cruz). The mixture of DyLight 488-Conjugated Goat Anti-Rabbit (Abbkine, Calif, USA) and DyLight 549-Conjugated Goat Anti-Mouse (Abbkine, Calif, USA) secondary antibodies was used to bind primary antibodies. Then the sections were mounted using mounting medium with 4',6-diamidino-2-phenylindole (DAPI) (ZSGB-Bio, Beijing, China), and photographed.
Statistical analysis
All experiments were independently repeated at least three times. The data were presented as the means±SEM. Comparisons were determined by using a two-tailed Student's t-test between two groups; One-way ANOVA was used for more than two groups. P<0.05 were considered as statistically significant.
Results
Endogenous Panx3 expression during osteogenic differentiation of hDPSCs
To elucidate whether the expression of endogenous Panx3 was influenced upon osteogenic differentiation of hDPSCs, hDPSCs were incubated in OM. The results showed that Panx3 expression was significantly enhanced at days 4 and 7 compared to day 0 (Fig.  1A-C) . These findings indicated that Panx3 might participate into osteogenic differentiation of primary hDPSCs.
Panx3 is required for proliferation and osteogenic differentiation of hDPSCs
For functional analysis of Panx3, we overexpressed and silenced Panx3 expression using lenti-Panx3, lenti-Plvx, lenti-shRNA-Panx3 and lenti-shRNA-Ctrl lentiviruses. Transduction efficiencies of the lentiviruses were verified by fluorescence microscopy (Fig. 1D) , qRT-PCR (Fig. 1E, F) and Western blot (Fig. 1G, H) .
To analyze the effect of Panx3 on the proliferation of hDPSCs, CCK-8 assay was performed. The proliferation rate was significantly decreased in hDPSCs/Panx3 cells compared with that in hDPSCs/Plvx cells. Furthermore, Panx3 knockdown enhanced cell proliferation compared with that in control cells ( Fig. 2A) . Meanwhile, p21 mRNA expression level was upregulated in hDPSCs/Panx3 but decreased in hDPSCs/shRNA compared with respective control groups (Fig. 2B) .
To further evaluate the effect of Panx3 in osteogenic differentiation of hDPSCs, the four groups were induced to differentiation. We found that overexpression of Panx3 promoted differentiation of hDPSCs as evidenced by increased expression of mineralization-related (Fig. 2C-G) and enhanced in vitro extracellular matrix (ECM) formation visualized by ALP staining and alizarin red staining (Fig. 2H-J) . By contrast, Panx3 knockdown remarkably diminished the osteogenic differentiation of hDPSC ( Fig. 2C-J) .
Panx3 represses the Wnt/β-catenin signaling pathway and the promotive effect of Panx3 on osteogenic differentiation is not dependent on the Wnt/β-catenin signaling pathway
Wnt/β-catenin signaling plays critical roles in developmental processes such as differentiation, proliferation and bone regeneration. Therefore, we investigated the effect of Panx3 on this pathway. Some commonly used markers of Wnt/β-catenin activation are (a) the phosphorylation level of β-catenin, (b) the nuclear translocation of β-catenin, (c) the interaction between β-catenin and TCF/LEF transcription factor. In our investigations, western blot analysis showed that Panx3 overexpression increased the phosphorylation level of β-catenin, but decreased total β-catenin expression (Fig. 3A) . Immunofluorescence analysis demonstrated that Panx3 overexpression exhibited weaker nuclear staining of β-catenin compared to control cells (Fig. 3B) . In addition, the mRNA expression of β-catenin was enhanced in hDPSCs/shRNA cells but decreased in the hDPSCs/Panx3 group (Fig. 3C ). In 
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contrast, Panx3-knockdown cells showed adverse tendency compared with control cells (Fig.  3A) . To assess whether the transcriptional activities of β-catenin were regulated by Panx3, we performed a TOPflash/FOPflash luciferase reporter assay in hDPSCs. Dual-luciferase reporter assay showed that Panx3 overexpression retarded Wnt/β-catenin transcription activity by 66%, and Panx3 knockdown increased it by approximately 1.2-fold upon 20 mM LiCl stimulation for 24 hr (Fig. 3D) . Taken together, these findings suggest that Panx3 inactivated Wnt/β-catenin in hDPSCs.
To investigate whether Panx3 positively controls differentiation via inactivation of Wnt/ β-catenin, we used LiCl to activate Wnt/β-catenin signaling and attempted to reverse the higher differentiation abilities of the hDPSCs/Panx3 group. Surprisingly, instead of reversing the promoting effect of Panx3 overexpression on differentiation, LiCl even enhanced the effect. In addition, expressions of mineralization-related markers were significantly increased in LiCl-treated hDPSCs/shRNA cells than that in untreated groups (Fig. 3E-H) . Overall, these data showed that Wnt/β-catenin did not contribute to increase in osteogenic differentiation in the hDPSCs/Panx3 group. 
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Panx3 is a target of Wnt/β-catenin Subsequently, we investigated whether Panx3 expression is affected by Wnt/β-catenin signaling. Using Genomatix MatInspector software, we found TCF/LEF binding sites within the candidate promoter sequence of Panx3. We then screened the Panx3 promoter regions from mammalian species, human, canine, and mice, for potential TCF/LEF-binding sites (Fig 4A) . All three Panx3 promoters in both directions contained the TCF/LEF consensus sequence A/TA/TCAAAG [22, 23] . This suggested that Panx3 might be a target of the Wnt/β-catenin signaling pathway. We then treated hDPSCs cells with Wnt3a-conditioned medium or LiCl for up to 24 h and performed Western blot analysis. Similar to β-catenin expression, Wnt3a-conditioned medium (0, 10%, 20%, 40% and 80%) and LiCl (0, 5mM, 10mM, 20mM) progressively enhanced Panx3 protein expression (Fig. 4B, C) . We then genetically repressed Wnt/β-catenin signaling activity using β-catenin-shRNA. Knockdown of β-catenin lessened Panx3 expression (Fig. 4D) . Immunofluorescence analysis confirmed these results (Fig. 4E) . Next, we cloned the potential human Panx3 promoter (the 5ʹ-flanking 2-kb region of the Panx3 gene transcription start site) into the pGL3-basic luciferase reporter vector (Fig. 4F ) and performed dual-luciferase reporter experiments. Dual-luciferase assay showed that LiCl considerably enhanced the Panx3 promoter activity (Fig. 4G) . These findings indicate that Wnt/β-catenin positively regulates Panx3 expression.
Panx3 controls differentiation of hDPSCs via activation of the ERK1/2 signaling pathway
ERK signaling pathway is a critical regulator of MSCs and positively modulate osteogenic differentiation [24] . Western blot analysis showed enhanced phosphorylation level of ERK1/2 in the hDPSCs/Panx3 group, whereas p-ERK1/2 level was decreased in the hDPSCs/shRNA group (Fig. 5A) . Accordingly, U0126, a specific inhibitor of the ERK1/2 signaling pathway, Cellular Physiology and Biochemistry
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significantly impaired the effect of Panx3 on osteogenic differentiation, including reduced expression of mineralization-related markers, lessened ALP activity, and less mineralization of ECM as assessed by ARS staining (Fig. 5B-F) in the U0126-treated hDPSCs/Panx3 group compared with those in the hDPSCs/Panx3 group. Collectively, these results demonstrate that Panx3 promotes osteogenic differentiation by upregulating ERK signaling pathway.
Reinforced Panx3 overexpression accelerates bone repair in vivo
To support the in vitro results that Panx3 promotes osteogenic differentiation of hDPSCs, we next analyzed the ability of Panx3 for bone repair by using a rat cranial critical-sized bone defect model. μCT (Fig. 6A , the first line) and histomorphometric analysis (Fig. 6B) showed that hDPSCs/Panx3-β-TCP group displayed more bone formation than hDPSCs/Plvx-β-TCP at 8 weeks post-operation even though the defect was not completely restored. A small amount of newly formed bone was detected in the β-TCP only group, and almost no newly formed bone was detected in the blank group.
Histological analysis showed that the newly formed bone area in the hDPSCs/Panx3-β-TCP group was 1.8-fold greater than that in the hDPSCs/Plvx-β-TCP group (Fig. 6A, C) . The β-TCP alone group showed higher bone formation than blank group. The scaffolds almost degraded in 8 weeks. Hardly any newly formed bone was present in the blank group. TRAP Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry staining showed that osteoclasts were presented in the border of the newly formed bone (Fig. 6A, the last line) . To identify the origin and status of implanted hDPSCs in newly formed bone, double immunofluorescence staining of OCN and GFP was performed (Fig. 7) . GFP-positive cells 
Discussion
hDPSCs have been increasingly exploited as seed cells for cell-based bone regeneration, which has motivated research in the field of hDPSCs differentiation. The development of gene therapy has become one of most promising hot points for bone tissue engineering. To date, no reports have been published on the effect of Panx3 on osteogenic differentiation of hDPSCs in vitro and in vivo. This study is the first to investigate these phenomena.
In the present study, we showed that Panx3 was upregulated upon osteogenic commitment. Accordingly, Panx3 overexpression inhibits proliferation and promotes differentiation of hDPSCs, whereas Panx3 silencing plays an opposite effect on proliferation and differentiation. Moreover, in vivo experimental results revealed that Panx3 overexpressing hDPSCs accelerate new bone formation and healing of bone defects. This is consistent with previous studies that Panx3 positively regulates osteogenesis of mice pre-osteoblasts. Ishikawa et al. demonstrated that Panx3 functions as a hemichannel allowing intracellular ATP release into the extracellular space. Extracellular ATP binds to purinergic receptors, activating PI3K/Akt and thereby influencing key downstream factors involved in osteogenic differentiation [15] . However, the molecular mechanisms behind Panx3 function during osteogenic differentiation of hDPSCs are still undefined.
A previous study showed that Panx3 could inhibit proliferation of murine osteoprogenitors through inhibition of the Wnt signaling pathway [25] . Wnt/β-catenin signaling pathway not only regulates cell proliferation but also orchestrates differentiation in various cell types. Notably, Wnt/β-catenin has been demonstrated to play a controversial modulatory role in osteogenic differentiation [26] [27] [28] . These discrepancies prompted us to question whether Panx3 regulates osteoblast differentiation of hDPSCs through canonical Wnt/β-catenin signaling. In the current study, Panx3 overexpression in hDPSCs inactivated Wnt/β-catenin transcriptional activity, whereas Panx3-silencing hDPSCs had an opposite effect. This is in agreement with the study by Ishikawa et al. in which Panx3 was found to promote β-catenin degradation through GSK3β activation [25] . Therefore, we postulated that Panx3 may regulate differentiation through downregulating Wnt/β-catenin. To test this postulation, hDPSCs/Panx3 cells were incubated with LiCl (20 mM), a Wnt/β-catenin agonist for activating Wnt/β-catenin. Instead of reversing the upregulation of mineralization-related markers, LiCl further exacerbated osteogenic differentiation of Panx3-overexpressed cells. LiCl also promoted the osteogenic differentiation of Panx3 knockdown hDPSCs. Therefore, it is reasonable to conclude that Wnt/β-catenin signaling plays a positive role in osteogenic differentiation of hDPSCs, but the promotive effect of Panx3 on differentiation of hDPSCs may not be attributed to suppression of the Wnt/β-catenin signaling pathway. This finding is in agreement with a previous study showing that Wnt/β-catenin promotes odonto/ osteogenic differentiation of stem cells of dental apical papilla [29] .
Up to now, there are a few published studies on the upstream activators of Panx3. Result of bioinformatics analysis revealed that mammal putative Panx3 promoters contain several TCF/LEF binding consensus sites (A/TA/TCAAAG) [22, 23] . In this study, we discovered that both LiCl and Wnt3a-conditioned medium significantly up-regulated Panx3 protein level, concomitant with increase of β-catenin. Conversely, deletion of β-catenin impaired Panx3 protein expression. Wnt3a, one of the receptor ligands of Frizzled, could activate Wnt signaling [22] . LiCl activates the Wnt/β-catenin signaling pathway by inhibiting GSK3β [30] . Subsequently, we cloned the 5ʹ proximal region of the human Panx3 promoter into the pGL3-basic vector. Activation of Wnt signaling pathway using LiCl up-regulated Panx3 promoter activity. Collectively, our studies provide the first evidence that Wnt/β-catenin signaling transcriptionally regulates Panx3 expression, and thereby forms a feedback loop.
The ERK signaling pathway is important in osteogenic commitment of various cell types [24, 31, 32] . In the present study, we demonstrated that Panx3 overexpression enhanced ERK activity. Additionally, U0126, an inhibitor of ERK signaling pathway, could retard the enhanced osteogenic differentiation ability of Panx3 overexpression in hDPSCs. However, the molecular mechanism of this cellular event remains elusive. One possible explanation is that Panx3 functions as a hemichannel mediating ATP release from the cytoplasm into extracellular environments [33] . Likewise, extracellular ATP could activate the ERK signaling pathway [34] [35] [36] , partially explaining the promotive implication of Panx3 on the ERK pathway. Certainly, this is unlikely to be the sole mechanism of Panx3-induced upregulation of osteogenic differentiation.
In order to verify the clinical potential of Panx3-modified hDPSCs in cell-based therapy, a rat cranial critical-sized bone defect model was used to test the bone repair capacity of modified hDPSCs in vivo. In our study, no immune cells were activated and recruited to the injured sites. This is consistent with previous studies that have reported absence of immune rejection and teratoma formation upon transplantation of hDPSCs into immunocompetent animals such as mice, rats and monkeys [37] . Moreover, immunosuppressive activity was higher in hDPSCs than MSCs [38] . Due to their low immunogenicity and low rates of transplantation rejection, it is not necessary to match recipients and donor for hDPSCs transplantation [39, 40] . A three-dimensional scaffold capable of supporting bone formation is crucial for bone regeneration. β-TCP scaffold has high porosity and interconnectivity and is a good osteo-conductive material that has been commonly used in bone defects repair [41] . For this reason, β-TCP was chosen as scaffold in our study. GFP was used as a marker of transplanted cells. Detection of GFP in the osteocytes in hDPSCsS/Panx3-β-TCP and hDPSCs/ Plvx-β-TCP groups indicates that hDPSCs could survive for a long time and ossify in vivo [42] . In addition, this result showed that Panx3 modified hDPSCs could directly enhance osteogenicity. However, some GFP-/OCN+ cells were detected in all the groups, indicating Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry that the bone defects were repaired through the collective effects of both transplanted and host cells. In summary, our experiments demonstrated that Panx3 plays an essential role in the regulation of osteogenic differentiation by activating ERK signaling pathways. Additionally, our findings indicate a bi-directional interaction between Panx3 and Wnt/β-catenin. In a rat cranial critical-sized bone defect model, Panx3-modified hDPSCs could improve bone repair. Collectively, our results provide the first set of evidence supporting the model that Panx3 functions as an endogenous activator of hDPSC osteogenic commitment. Thus, Panx3-modifed hDPSCs show promise for use in bone tissue engineering. Nonetheless, whether the promotive effect of Panx3 on differentiation was a consequence of addition of Panx3 hemichannel function or a systematic Panx3 protein overexpression needs to be distinguished. Moreover, the direct interaction between Panx3 and signaling pathway warrants further exploration.
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